Perplexity AI is in the final stages of raising $500 million in funding at a $9 billion valuation, a source familiar with the situation told CNBC.
Related Posts
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the U.S. – his administration’s bid to boost manufacturing in the country.
How Uniqlo’s functional clothing has won over the U.S.
Uniqlo is growing in the U.S. as its functional clothes at a reasonable price point win over consumers.
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.